Improving Heart Failure Care in Florida
A leading medical center in Central Florida has made a significant advancement in its heart failure treatment by incorporating Daxor’s BVA-100™ blood volume diagnostic technology. This initiative reflects their commitment to delivering outstanding patient care and enhancing clinical processes.
Introducing the ezBVA Lab Program
Daxor Corporation (Nasdaq: DXR), a global leader in blood volume measurement, is launching its cutting-edge ezBVA Lab service. This service is designed to efficiently handle blood volume analysis tests, providing rapid results within 24 hours. Such capabilities are essential for healthcare facilities that aim to improve operational efficiency and patient outcomes.
The Significance of Blood Volume Analysis
Assessing blood volume is vital in managing heart failure, as it helps determine a patient's volume status. This understanding is crucial for both inpatient and outpatient care protocols. Daxor’s BVA technology delivers precise measurements, allowing healthcare providers to offer personalized care that meets the unique needs of each patient.
Daxor’s Dedication to Patient Care
“Effective volume management is essential in heart failure treatment,” stated Michael Feldschuh, CEO and President of Daxor. He highlighted that Daxor's BVA technology delivers highly accurate data that can significantly improve patient outcomes. With the ezBVA Lab service, hospitals can utilize this innovative technology without a large upfront investment, as the service qualifies for reimbursement under established CPT codes.
About Daxor Corporation
Daxor Corporation is at the forefront of blood volume assessment technology, committed to advancing healthcare through significant innovations. The BVA-100™ is the only FDA-approved diagnostic tool for accurately measuring blood volume and its composition, enabling better clinical decisions. With over 65,000 tests performed at leading hospitals, Daxor is dedicated to enhancing healthcare metrics, especially in managing heart failure and critical care conditions.
Looking Ahead: Future Innovations
The company is also engaged in ongoing trials related to heart failure treatment, supported by reputable organizations, and has contracts aimed at improving military medical capabilities. Daxor's mission is to promote optimal fluid management through blood volume analysis, aspiring to a future where effective blood volume management benefits all patients.
Frequently Asked Questions
What does the BVA-100™ do?
The BVA-100™ accurately measures blood volume and its composition, which is crucial for effective management of heart failure.
How quickly can results be obtained from the ezBVA Lab?
The ezBVA Lab streamlines the testing process, providing results in approximately 24 hours, which significantly enhances turnaround times for patient care.
Can hospitals without capital invest in this technology?
Yes, Daxor’s ezBVA Lab service enables hospitals to access this diagnostic technology without a substantial initial investment, as it is reimbursable by insurance.
How many tests have been performed using Daxor’s technology?
More than 65,000 blood volume tests have been conducted across numerous top hospital centers in the U.S.
What is the mission of Daxor Corporation?
Daxor's mission is to enhance healthcare outcomes by facilitating optimal fluid management through advanced blood volume analysis technologies.
